Skip to main content
Erschienen in: Journal of Neural Transmission 2/2018

07.12.2017 | Neurology and Preclinical Neurological Studies - Original Article

An unexpected improvement in spatial learning and memory ability in alpha-synuclein A53T transgenic mice

verfasst von: Qi Liu, YuYu Xu, WenPing Wan, ZeGang Ma

Erschienen in: Journal of Neural Transmission | Ausgabe 2/2018

Einloggen, um Zugang zu erhalten

Abstract

Growing evidence suggests, as Parkinson’s disease (PD) progresses, that its non-motor symptoms appear prior to or in parallel with its motor deficits. Alpha-synuclein A53T transgenic mouse (A53T) is an essential tool to investigate the onsets and the extents of PD non-motor symptoms. Our aim is to investigate spatial learning and memory ability in A53T mice. In our rotarod tests, no motor coordination impairments were detected in mice of 3, 6, 9, and 12 months old. We then investigated their spatial learning and memory ability through Morris water maze in 3- and 9-month-old mice. No significant difference in escape latency was detected among the A53T mice and the control mice. However, an unexpected improvement in spatial learning and memory ability was observed in the probe session among the A53T mice. Reversal learning by Morris water maze also indicated that 3- and 9-month-old A53T mice exhibited a better cognitive flexibility compared to their littermate controls. Further studies by western blots showed that alpha-synuclein expressions in hippocampus of the A53T mice were noticeably up-regulated. The immunofluorescence staining of 5-bromo-2-deoxyuridine (Brdu) and doublecortin (DCX) demonstrated that neither the Brdu-positive neurons nor the Brdu/DCX positive neurons in hippocampus were significantly altered between the two groups. These results suggest that our A53T mice exhibit improved spatial learning and memory ability prior to their motor coordination deficits. These results are not induced by neurogenesis in the hippocampus.
Literatur
Zurück zum Zitat Bellucci A, Navarria L, Zaltieri M, Missale C, Spano P (2012) Alpha-synuclein synaptic pathology and its implications in the development of novel therapeutic approaches to cure Parkinson’s disease. Brain Res 1432:95–113CrossRefPubMed Bellucci A, Navarria L, Zaltieri M, Missale C, Spano P (2012) Alpha-synuclein synaptic pathology and its implications in the development of novel therapeutic approaches to cure Parkinson’s disease. Brain Res 1432:95–113CrossRefPubMed
Zurück zum Zitat Cabin DE, Shimazu K, Murphy D, Cole NB, Gottschalk W, McIlwain KL, Orrison B, Chen A, Ellis CE, Paylor R, Lu B, Nussbaum RL (2002) Synaptic vesicle depletion correlates with attenuated synaptic responses to prolonged repetitive stimulation in mice lacking alpha-synuclein. J Neurosci 22(20):8797–8807PubMed Cabin DE, Shimazu K, Murphy D, Cole NB, Gottschalk W, McIlwain KL, Orrison B, Chen A, Ellis CE, Paylor R, Lu B, Nussbaum RL (2002) Synaptic vesicle depletion correlates with attenuated synaptic responses to prolonged repetitive stimulation in mice lacking alpha-synuclein. J Neurosci 22(20):8797–8807PubMed
Zurück zum Zitat Calo L, Wegrzynowicz M, Santivanez-Perez J, Grazia Spillantini M (2016) Synaptic failure and alpha-synuclein. Mov Disord 31(2):169–177CrossRefPubMed Calo L, Wegrzynowicz M, Santivanez-Perez J, Grazia Spillantini M (2016) Synaptic failure and alpha-synuclein. Mov Disord 31(2):169–177CrossRefPubMed
Zurück zum Zitat Chen PE, Specht CG, Morris RG, Schoepfer R (2002) Spatial learning is unimpaired in mice containing a deletion of the alpha-synuclein locus. Eur J Neurosci 16(1):154–158CrossRefPubMed Chen PE, Specht CG, Morris RG, Schoepfer R (2002) Spatial learning is unimpaired in mice containing a deletion of the alpha-synuclein locus. Eur J Neurosci 16(1):154–158CrossRefPubMed
Zurück zum Zitat Clayton DF, George JM (1999) Synucleins in synaptic plasticity and neurodegenerative disorders. J Neurosci Res 58(1):120–129CrossRefPubMed Clayton DF, George JM (1999) Synucleins in synaptic plasticity and neurodegenerative disorders. J Neurosci Res 58(1):120–129CrossRefPubMed
Zurück zum Zitat Ferrer I, Lopez-Gonzalez I, Carmona M, Dalfo E, Pujol A, Martinez A (2012) Neurochemistry and the non-motor aspects of PD. Neurobiol Dis 46(3):508–526CrossRefPubMed Ferrer I, Lopez-Gonzalez I, Carmona M, Dalfo E, Pujol A, Martinez A (2012) Neurochemistry and the non-motor aspects of PD. Neurobiol Dis 46(3):508–526CrossRefPubMed
Zurück zum Zitat Garthe A, Behr J, Kempermann G (2009) Adult-generated hippocampal neurons allow the flexible use of spatially precise learning strategies. PLoS One 4(5):e5464CrossRefPubMedPubMedCentral Garthe A, Behr J, Kempermann G (2009) Adult-generated hippocampal neurons allow the flexible use of spatially precise learning strategies. PLoS One 4(5):e5464CrossRefPubMedPubMedCentral
Zurück zum Zitat George JM, Jin H, Woods WS, Clayton DF (1995) Characterization of a novel protein regulated during the critical period for song learning in the zebra finch. Neuron 15(2):361–372CrossRefPubMed George JM, Jin H, Woods WS, Clayton DF (1995) Characterization of a novel protein regulated during the critical period for song learning in the zebra finch. Neuron 15(2):361–372CrossRefPubMed
Zurück zum Zitat George S, van den Buuse M, San Mok S, Masters CL, Li QX, Culvenor JG (2008) Alpha-synuclein transgenic mice exhibit reduced anxiety-like behaviour. Exp Neurol 210(2):788–792CrossRefPubMed George S, van den Buuse M, San Mok S, Masters CL, Li QX, Culvenor JG (2008) Alpha-synuclein transgenic mice exhibit reduced anxiety-like behaviour. Exp Neurol 210(2):788–792CrossRefPubMed
Zurück zum Zitat Giasson BI, Duda JE, Quinn SM, Zhang B, Trojanowski JQ, Lee VM (2002) Neuronal alpha-synucleinopathy with severe movement disorder in mice expressing A53T human alpha-synuclein. Neuron 34(4):521–533CrossRefPubMed Giasson BI, Duda JE, Quinn SM, Zhang B, Trojanowski JQ, Lee VM (2002) Neuronal alpha-synucleinopathy with severe movement disorder in mice expressing A53T human alpha-synuclein. Neuron 34(4):521–533CrossRefPubMed
Zurück zum Zitat Graham DR, Sidhu A (2010) Mice expressing the A53T mutant form of human alpha-synuclein exhibit hyperactivity and reduced anxiety-like behavior. J Neurosci Res 88(8):1777–1783PubMedPubMedCentral Graham DR, Sidhu A (2010) Mice expressing the A53T mutant form of human alpha-synuclein exhibit hyperactivity and reduced anxiety-like behavior. J Neurosci Res 88(8):1777–1783PubMedPubMedCentral
Zurück zum Zitat Guerreiro PS, Coelho JE, Sousa-Lima I, Macedo P, Lopes LV, Outeiro TF, Pais TF (2017) Mutant A53T alpha-synuclein improves rotarod performance before motor deficits and affects metabolic pathways. Neuromol Med 19(1):113–121CrossRef Guerreiro PS, Coelho JE, Sousa-Lima I, Macedo P, Lopes LV, Outeiro TF, Pais TF (2017) Mutant A53T alpha-synuclein improves rotarod performance before motor deficits and affects metabolic pathways. Neuromol Med 19(1):113–121CrossRef
Zurück zum Zitat Hartman VN, Miller MA, Clayton DF, Liu WC, Kroodsma DE, Brenowitz EA (2001) Testosterone regulates alpha-synuclein mRNA in the avian song system. Neuroreport 12(5):943–946CrossRefPubMed Hartman VN, Miller MA, Clayton DF, Liu WC, Kroodsma DE, Brenowitz EA (2001) Testosterone regulates alpha-synuclein mRNA in the avian song system. Neuroreport 12(5):943–946CrossRefPubMed
Zurück zum Zitat Jia F, Song N, Zhao C, Xie J, Jiang H (2014) Unexpected improvements of spatial learning and memory abilities in chronic rotenone intoxicated mice. PLoS One 9(3):e91641CrossRefPubMedPubMedCentral Jia F, Song N, Zhao C, Xie J, Jiang H (2014) Unexpected improvements of spatial learning and memory abilities in chronic rotenone intoxicated mice. PLoS One 9(3):e91641CrossRefPubMedPubMedCentral
Zurück zum Zitat Kotzbauer PT, Giasson BI, Kravitz AV, Golbe LI, Mark MH, Trojanowski JQ, Lee VM (2004) Fibrillization of alpha-synuclein and tau in familial Parkinson’s disease caused by the A53T alpha-synuclein mutation. Exp Neurol 187(2):279–288CrossRefPubMed Kotzbauer PT, Giasson BI, Kravitz AV, Golbe LI, Mark MH, Trojanowski JQ, Lee VM (2004) Fibrillization of alpha-synuclein and tau in familial Parkinson’s disease caused by the A53T alpha-synuclein mutation. Exp Neurol 187(2):279–288CrossRefPubMed
Zurück zum Zitat Lam HA, Wu N, Cely I, Kelly RL, Hean S, Richter F, Magen I, Cepeda C, Ackerson LC, Walwyn W, Masliah E, Chesselet MF, Levine MS, Maidment NT (2011) Elevated tonic extracellular dopamine concentration and altered dopamine modulation of synaptic activity precede dopamine loss in the striatum of mice overexpressing human alpha-synuclein. J Neurosci Res 89(7):1091–1102CrossRefPubMedPubMedCentral Lam HA, Wu N, Cely I, Kelly RL, Hean S, Richter F, Magen I, Cepeda C, Ackerson LC, Walwyn W, Masliah E, Chesselet MF, Levine MS, Maidment NT (2011) Elevated tonic extracellular dopamine concentration and altered dopamine modulation of synaptic activity precede dopamine loss in the striatum of mice overexpressing human alpha-synuclein. J Neurosci Res 89(7):1091–1102CrossRefPubMedPubMedCentral
Zurück zum Zitat Lim Y, Kehm VM, Lee EB, Soper JH, Li C, Trojanowski JQ, Lee VM (2012) Alpha-Syn suppression reverses synaptic and memory defects in a mouse model of dementia with Lewy bodies. J Neurosci 31(27):10076–10087CrossRef Lim Y, Kehm VM, Lee EB, Soper JH, Li C, Trojanowski JQ, Lee VM (2012) Alpha-Syn suppression reverses synaptic and memory defects in a mouse model of dementia with Lewy bodies. J Neurosci 31(27):10076–10087CrossRef
Zurück zum Zitat Magen I, Fleming SM, Zhu C, Garcia EC, Cardiff KM, Dinh D, De La Rosa K, Sanchez M, Torres ER, Masliah E, Jentsch JD, Chesselet MF (2012) Cognitive deficits in a mouse model of pre-manifest Parkinson’s disease. Eur J Neurosci 35(6):870–882CrossRefPubMedPubMedCentral Magen I, Fleming SM, Zhu C, Garcia EC, Cardiff KM, Dinh D, De La Rosa K, Sanchez M, Torres ER, Masliah E, Jentsch JD, Chesselet MF (2012) Cognitive deficits in a mouse model of pre-manifest Parkinson’s disease. Eur J Neurosci 35(6):870–882CrossRefPubMedPubMedCentral
Zurück zum Zitat Palmeri R, Lo Buono V, Corallo F, Foti M, Di Lorenzo G, Bramanti P, Marino S (2017) Nonmotor symptoms in parkinson disease: a descriptive review on social cognition ability. J Geriatr Psychiatry Neurol 30(2):109–121CrossRefPubMed Palmeri R, Lo Buono V, Corallo F, Foti M, Di Lorenzo G, Bramanti P, Marino S (2017) Nonmotor symptoms in parkinson disease: a descriptive review on social cognition ability. J Geriatr Psychiatry Neurol 30(2):109–121CrossRefPubMed
Zurück zum Zitat Paumier KL, Sukoff Rizzo SJ, Berger Z, Chen Y, Gonzales C, Kaftan E, Li L, Lotarski S, Monaghan M, Shen W, Stolyar P, Vasilyev D, Zaleska M, Hirst DW, Dunlop J (2013) Behavioral characterization of A53T mice reveals early and late stage deficits related to Parkinson’s disease. PLoS One 8(8):e70274CrossRefPubMedPubMedCentral Paumier KL, Sukoff Rizzo SJ, Berger Z, Chen Y, Gonzales C, Kaftan E, Li L, Lotarski S, Monaghan M, Shen W, Stolyar P, Vasilyev D, Zaleska M, Hirst DW, Dunlop J (2013) Behavioral characterization of A53T mice reveals early and late stage deficits related to Parkinson’s disease. PLoS One 8(8):e70274CrossRefPubMedPubMedCentral
Zurück zum Zitat Petersen K, Olesen OF, Mikkelsen JD (1999) Developmental expression of alpha-synuclein in rat hippocampus and cerebral cortex. Neuroscience 91(2):651–659CrossRefPubMed Petersen K, Olesen OF, Mikkelsen JD (1999) Developmental expression of alpha-synuclein in rat hippocampus and cerebral cortex. Neuroscience 91(2):651–659CrossRefPubMed
Zurück zum Zitat Poirier AA, Aube B, Cote M, Morin N, Di Paolo T, Soulet D (2016) Gastrointestinal dysfunctions in Parkinson’s disease: symptoms and treatments. Parkinsons Dis 2016:6762528PubMedPubMedCentral Poirier AA, Aube B, Cote M, Morin N, Di Paolo T, Soulet D (2016) Gastrointestinal dysfunctions in Parkinson’s disease: symptoms and treatments. Parkinsons Dis 2016:6762528PubMedPubMedCentral
Zurück zum Zitat Recchia A, Debetto P, Negro A, Guidolin D, Skaper SD, Giusti P (2004) Alpha-synuclein and Parkinson’s disease. FASEB J 18(6):617–626CrossRefPubMed Recchia A, Debetto P, Negro A, Guidolin D, Skaper SD, Giusti P (2004) Alpha-synuclein and Parkinson’s disease. FASEB J 18(6):617–626CrossRefPubMed
Zurück zum Zitat Trinchero MF, Koehl M, Bechakra M, Delage P, Charrier V, Grosjean N, Ladeveze E, Schinder AF, Abrous DN (2015) Effects of spaced learning in the water maze on development of dentate granule cells generated in adult mice. Hippocampus 25(11):1314–1326CrossRefPubMed Trinchero MF, Koehl M, Bechakra M, Delage P, Charrier V, Grosjean N, Ladeveze E, Schinder AF, Abrous DN (2015) Effects of spaced learning in the water maze on development of dentate granule cells generated in adult mice. Hippocampus 25(11):1314–1326CrossRefPubMed
Zurück zum Zitat Trojanowski JQ, Goedert M, Iwatsubo T, Lee VM (1998) Fatal attractions: abnormal protein aggregation and neuron death in Parkinson’s disease and Lewy body dementia. Cell Death Differ 5(10):832–837CrossRefPubMed Trojanowski JQ, Goedert M, Iwatsubo T, Lee VM (1998) Fatal attractions: abnormal protein aggregation and neuron death in Parkinson’s disease and Lewy body dementia. Cell Death Differ 5(10):832–837CrossRefPubMed
Zurück zum Zitat Winner B, Regensburger M, Schreglmann S, Boyer L, Prots I, Rockenstein E, Mante M, Zhao C, Winkler J, Masliah E, Gage FH (2012) Role of alpha-synuclein in adult neurogenesis and neuronal maturation in the dentate gyrus. J Neurosci 32(47):16906–16916CrossRefPubMedPubMedCentral Winner B, Regensburger M, Schreglmann S, Boyer L, Prots I, Rockenstein E, Mante M, Zhao C, Winkler J, Masliah E, Gage FH (2012) Role of alpha-synuclein in adult neurogenesis and neuronal maturation in the dentate gyrus. J Neurosci 32(47):16906–16916CrossRefPubMedPubMedCentral
Zurück zum Zitat Yang Y, Tang BS, Guo JF (2017) Parkinson’s disease and cognitive impairment. Parkinsons Dis 2016:6734678 Yang Y, Tang BS, Guo JF (2017) Parkinson’s disease and cognitive impairment. Parkinsons Dis 2016:6734678
Zurück zum Zitat Zhang S, Xiao Q, Le W (2015) Olfactory dysfunction and neurotransmitter disturbance in olfactory bulb of transgenic mice expressing human A53T mutant alpha-synuclein. PLoS One 10(3):e0119928CrossRefPubMedPubMedCentral Zhang S, Xiao Q, Le W (2015) Olfactory dysfunction and neurotransmitter disturbance in olfactory bulb of transgenic mice expressing human A53T mutant alpha-synuclein. PLoS One 10(3):e0119928CrossRefPubMedPubMedCentral
Zurück zum Zitat Zhang TM, Yu SY, Guo P, Du Y, Hu Y, Piao YS, Zuo LJ, Lian TH, Wang RD, Yu QJ, Jin Z, Zhang W (2016) Nonmotor symptoms in patients with Parkinson disease: A cross-sectional observational study. Medicine (Baltimore) 95(50):e5400CrossRef Zhang TM, Yu SY, Guo P, Du Y, Hu Y, Piao YS, Zuo LJ, Lian TH, Wang RD, Yu QJ, Jin Z, Zhang W (2016) Nonmotor symptoms in patients with Parkinson disease: A cross-sectional observational study. Medicine (Baltimore) 95(50):e5400CrossRef
Zurück zum Zitat Zhou Y, Takahashi E, Li W, Halt A, Wiltgen B, Ehninger D, Li GD, Hell JW, Kennedy MB, Silva AJ (2007) Interactions between the NR2B receptor and CaMKII modulate synaptic plasticity and spatial learning. J Neurosci 27(50):13843–13853CrossRefPubMed Zhou Y, Takahashi E, Li W, Halt A, Wiltgen B, Ehninger D, Li GD, Hell JW, Kennedy MB, Silva AJ (2007) Interactions between the NR2B receptor and CaMKII modulate synaptic plasticity and spatial learning. J Neurosci 27(50):13843–13853CrossRefPubMed
Metadaten
Titel
An unexpected improvement in spatial learning and memory ability in alpha-synuclein A53T transgenic mice
verfasst von
Qi Liu
YuYu Xu
WenPing Wan
ZeGang Ma
Publikationsdatum
07.12.2017
Verlag
Springer Vienna
Erschienen in
Journal of Neural Transmission / Ausgabe 2/2018
Print ISSN: 0300-9564
Elektronische ISSN: 1435-1463
DOI
https://doi.org/10.1007/s00702-017-1819-3

Weitere Artikel der Ausgabe 2/2018

Journal of Neural Transmission 2/2018 Zur Ausgabe

Neurology and Preclinical Neurological Studies - Original Article

Botulinum toxin therapy in patients with oral anticoagulation: is it safe?

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.